[CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
作者信息
Steinert Tilman
机构信息
Zentrum für Psychiatrie, Die Weissenau, Weingartshoferstr. 2, 88214 Ravensburg.
出版信息
Psychiatr Prax. 2007 Jul;34(5):255-7. doi: 10.1055/s-2007-984998.
PMID:17607643
Abstract
摘要
相似文献
1
[CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Psychiatr Prax. 2007 Jul;34(5):255-7. doi: 10.1055/s-2007-984998.
2
["Higher outcomes"--optimizing therapy of schizophrenia].["更高的疗效"——优化精神分裂症的治疗]
Krankenpfl J. 2004;42(5-6):151.
3
[Lifelong relapse prevention with antipsychotics in schizophrenia].[使用抗精神病药物对精神分裂症进行终身复发预防]
Psychiatr Prax. 2010 Sep;37(6):268-70. doi: 10.1055/s-0030-1248517. Epub 2010 Aug 27.
4
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Encephale. 2009 Jan;Suppl 3:S91-5. doi: 10.1016/S0013-7006(09)75543-5.
5
[Combining effectiveness and tolerance].[兼顾有效性与耐受性]
Krankenpfl J. 2005;43(1-3):26-7.
6
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].[对长效非典型抗精神病药物阿立哌唑的专家意见。如何评估观察质量]
Encephale. 2009 Jan;Suppl 3:S87-90. doi: 10.1016/S0013-7006(09)75542-3.
7
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.抗精神病药物依从性评估中患者与临床医生观点的比较。
Psychopathology. 2009;42(5):311-7. doi: 10.1159/000232973. Epub 2009 Aug 11.
8
Long-term treatment with flupentixol results of a post-marketing surveillance study.氟哌噻吨长期治疗的上市后监测研究结果。
J Psychopharmacol. 2009 Sep;23(7):805-13. doi: 10.1177/0269881108091879. Epub 2008 Jun 18.
9
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
Encephale. 2009 Jan;Suppl 3:S97-100. doi: 10.1016/S0013-7006(09)75544-7.
10
[The (new) definition of compliance].[依从性的（新）定义]
Krankenpfl J. 2005;43(7-10):214-5.
Zotero 插件